Israel Englander’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.4K Sell
37,677
-74,746
-66% -$79.3K ﹤0.01% 5669
2026
Q1
$183K Sell
112,423
-11,667
-9% -$19.9K ﹤0.01% 5210
2025
Q4
$221K Sell
124,090
-23,333
-16% -$48.6K ﹤0.01% 5424
2025
Q3
$355K Buy
147,423
+130,405
+766% +$316K ﹤0.01% 5266
2025
Q2
$38.6K Hold
17,018
﹤0.01% 5637
2025
Q1
$45.8K Sell
17,018
-313,981
-95% -$889K ﹤0.01% 5548
2024
Q4
$867K Sell
330,999
-68,819
-17% -$185K ﹤0.01% 4317
2024
Q3
$1.07M Sell
399,818
-21,907
-5% -$59.8K ﹤0.01% 4221
2024
Q2
$1.06M Buy
421,725
+96
+0% +$225 ﹤0.01% 4075
2024
Q1
$970K Buy
421,629
+73,355
+21% +$198K ﹤0.01% 4320
2023
Q4
$979K Buy
348,274
+142,448
+69% +$410K ﹤0.01% 4183
2023
Q3
$675K Buy
+205,826
New +$657K ﹤0.01% 4470
2023
Q2
Sell
-12,251
Closed -$14K 6510
2023
Q1
$14K Buy
+12,251
New +$14.3K ﹤0.01% 5950
2022
Q3
Sell
-14,191
Closed -$28K 7360
2022
Q2
$28K Buy
+14,191
New +$33.7K ﹤0.01% 6392
2018
Q2
Sell
-17
Closed -$13K 4053
2018
Q1
$13K Buy
+17
New +$58.5K ﹤0.01% 3573

Other funds holding NSPR

Israel Englander's NSPR Position: Q2 2026 in Review

Israel Englander reduced its InspireMD (NSPR) stake by 66% in Q2 2026, selling an estimated $79.3K and leaving 37,677 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5669.

Israel Englander first reported a position in NSPR in Q1 2018 and has held it in 15 quarters since. The position peaked at $1.07M in Q3 2024. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Israel Englander held 37,677 shares of InspireMD worth $26.4K as of Q2 2026.
  • Israel Englander sold 74,746 InspireMD shares in Q2 2026, an estimated $79.3K.
  • InspireMD made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5669 holding.
  • Israel Englander first reported a position in InspireMD in Q1 2018 and has held it in 15 quarters since.
  • Israel Englander's InspireMD position peaked at $1.07M in Q3 2024.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.